Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer.

被引：0
作者：
Gennatas, C
Mouratidou, D
Tsavaris, N
Andreadis, C
Michalaki, V
Psychogios, J
Poulakaki, N
Gennatas, S
机构：
[1] Univ Athens, Areteion Hosp, Athens, Greece
[2] Theagenion Krankenhauses, Thessaloniki, Greece
[3] Univ Athens, Laiko Hosp, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：63S / 63S
页数：1
相关论文
共 50 条
[41]   Safety and efficacy of eribulin in combination with gemcitabine in patients with advanced triple negative breast cancer. [J].
Michalaki, Vasiliki ;
Fragulidis, Georgios ;
Kondis, Ioannis ;
Karvouni, Eleni ;
Dafnios, Nikolaos ;
Kotsiou, Antonia ;
Vassiliou, Ioannis ;
Papadimitriou, Christos .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[42]   Phase II study of antiangiogenic tyrosine kinase inhibitor apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative advanced breast cancer [J].
Zhu, A. ;
Yuan, P. ;
Wang, J. ;
Fan, Y. ;
Luo, Y. ;
Cai, R. ;
Zhang, P. ;
Li, Q. ;
Ma, F. ;
Xu, B. .
CANCER RESEARCH, 2019, 79 (04)
[43]   A phase II trial of salvage treatment with gemcitabine and S-1 combination in heavily pretreated patients with metastatic colorectal cancer. [J].
Sym, Sun Jin ;
Hong, Junshik ;
Jung, Minkyu ;
Park, Jinny ;
Cho, Eun Kyung ;
Lee, Jae Hoon ;
Lee, Won-Suk ;
Baek, Jeong-Heum ;
Shin, Dong Bok .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[44]   Addition of Bevacizumab to Vinorelbine-Platinum combination is efficacious in Heavily Pretreated HER2-Negative Metastatic Breast Cancer [J].
Ho, I. -Wei ;
Tseng, Yi-Ru ;
Liu, Chun-Yu ;
Tsai, Yi-Fang ;
Huang, Chi-Cheng ;
Tseng, Ling-Ming ;
Chao, Ta-Chung ;
Lai, Jiun-, I .
JOURNAL OF CANCER, 2025, 16 (05) :1726-1735
[45]   Combination of liposomal doxorubicine plus gemcitabine in heavily pretreated metastatic breast cancer patients: A single center experience. [J].
Pablo Fusco, Juan ;
Martin Romano, Patricia ;
Castanon Alvarez, Eduardo ;
Ceniceros, Lucia ;
Legaspi, Jairo ;
Espinos, Jaime ;
Gil-Bazo, Ignacio ;
Fernandez-Hidalgo, Oscar ;
Aramendia, Jose M. ;
Santisteban, Marta .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[46]   Phase II study of gemcitabine (G) and vinorelbine (V) in metastatic breast cancer. [J].
Donadio, M ;
Ritorto, G ;
Novarino, A ;
Bonazzi, G ;
Coccorullo, Z ;
Buffoni, L ;
Occelli, M ;
Bertetto, O .
ANNALS OF ONCOLOGY, 2000, 11 :31-31
[47]   Topotecan as single agent or in combination with carboplatin in pretreated and heavily pretreated patients with advanced ovarian cancer [J].
Martoni, A ;
Pelusi, G ;
De Jaco, P ;
Taroni, B ;
Cacciari, N ;
Angelelli, B ;
Marino, A ;
Zamagni, C .
7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, :253-256
[48]   Gemcitabine plus vinorelbine as first-line treatment of metastatic breast cancer. [J].
Gokmen, E ;
Sezgin, C ;
Karabulut, B ;
Vazquez, A ;
Sanal, S .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :85S-85S
[49]   Vinorelbine and gemcitabine is an effective and well tolerated combination for the treatment of patients with advanced non-small cell lung cancer. [J].
Beinert, T ;
Kahnt, C ;
Schweiger, M ;
Fleischhacker, M ;
Werner, TG ;
Binder, D ;
Mergenthaler, HG ;
Possinger, K .
ANNALS OF ONCOLOGY, 2000, 11 :110-110
[50]   Gemcitabine monotherapy in patients with heavily pretreated metastatic breast cancer. Evaluation of clinical activity and toxicity. NCI Slovakia Experience [J].
Salek, Tomas ;
Mardiak, J. ;
Dolinsky, J. ;
Koza, I. .
ANNALS OF ONCOLOGY, 2004, 15 :54-54
12345